{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:52:55Z","timestamp":1790787175824,"version":"4.1.0"},"reference-count":66,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Liver Disease"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.cld.2025.08.004","type":"journal-article","created":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T04:58:59Z","timestamp":1758949139000},"page":"45-54","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Alcohol-Related Liver Disease"],"prefix":"10.1016","volume":"30","author":[{"given":"Haripriya","family":"Maddur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Flamm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.cld.2025.08.004_bib1","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41572-018-0014-7","article-title":"Alcoholic liver disease","volume":"4","author":"Seitz","year":"2018","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"10.1016\/j.cld.2025.08.004_bib2","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nrgastro.2017.116","article-title":"Alcohol, adipose tissue and liver disease: mechanistic links and clinical considerations","volume":"15","author":"Parker","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.cld.2025.08.004_bib3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.alcohol.2004.07.008","article-title":"Alcoholic fatty liver: its pathogenesis and mechanism of progression to inflammation and fibrosis","volume":"34","author":"Lieber","year":"2004","journal-title":"Alcohol"},{"issue":"35","key":"10.1016\/j.cld.2025.08.004_bib4","doi-asserted-by":"crossref","first-page":"4746","DOI":"10.3748\/wjg.v13.i35.4746","article-title":"Role of iron in hepatic fibrosis: one piece in the puzzle","volume":"13","author":"Philippe","year":"2007","journal-title":"World J Gastroenterol"},{"issue":"2","key":"10.1016\/j.cld.2025.08.004_bib5","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1053\/j.gastro.2007.11.037","article-title":"Hepatic fatty acid transporter Cd36 is a common target of LXR, PXR, and PPARgamma in promoting steatosis","volume":"134","author":"Zhou","year":"2008","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.cld.2025.08.004_bib6","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1186\/s12967-023-04166-8","article-title":"Pathogenic mechanisms and regulatory factors involved in alcoholic liver disease","volume":"21","author":"Yan","year":"2023","journal-title":"J Transl Med"},{"issue":"5","key":"10.1016\/j.cld.2025.08.004_bib7","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1053\/jhep.2000.19621","article-title":"Exacerbation of alcoholic liver injury by enteral endotoxin in rats","volume":"32","author":"Mathurin","year":"2000","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.cld.2025.08.004_bib8","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1172\/JCI13505","article-title":"Role of AMP-activated protein kinase in mechanism of metformin action","volume":"108","author":"Zhou","year":"2001","journal-title":"J Clin Investig"},{"issue":"12","key":"10.1016\/j.cld.2025.08.004_bib9","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1016\/S0891-5849(01)00744-4","article-title":"Distribution of ethanol-induced protein adducts in vivo: relationship to tissue injury","volume":"31","author":"Niemel\u00e4","year":"2001","journal-title":"Free Radic Biol Med"},{"issue":"2","key":"10.1016\/j.cld.2025.08.004_bib10","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.jhep.2018.12.003","article-title":"Fibrosis and alcohol-related liver disease","volume":"70","author":"Lackner","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.cld.2025.08.004_bib11","doi-asserted-by":"crossref","first-page":"2","DOI":"10.21037\/tgh.2019.09.06","article-title":"Genetic and epigenetic disease modifiers: non-alcoholic fatty liver disease (NAFLD) and alcoholic liver disease (ALD)","volume":"6","author":"Choudhary","year":"2021","journal-title":"Transl Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.cld.2025.08.004_bib12","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1002\/med.21881","article-title":"Epigenetic modification in alcohol-related liver diseases","volume":"42","author":"Ajoolabady","year":"2022","journal-title":"Med Res Rev"},{"issue":"2","key":"10.1016\/j.cld.2025.08.004_bib13","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1096\/fj.201800736R","article-title":"Chronic ethanol-mediated hepatocyte apoptosis links to decreased TET1 and 5-hydroxymethylcytosine formation","volume":"33","author":"Ji","year":"2019","journal-title":"FASEB J"},{"issue":"8","key":"10.1016\/j.cld.2025.08.004_bib14","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1111\/liv.15600","article-title":"Inhibition of ACSS2 attenuates alcoholic liver steatosis via epigenetically regulating de novo lipogenesis","volume":"43","author":"Lu","year":"2023","journal-title":"Liver Int"},{"issue":"5","key":"10.1016\/j.cld.2025.08.004_bib15","article-title":"Epigenetics of alcohol-related liver diseases","volume":"4","author":"Habash","year":"2022","journal-title":"JHEP Rep"},{"issue":"2","key":"10.1016\/j.cld.2025.08.004_bib16","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","article-title":"MicroRNAs: target recognition and regulatory functions","volume":"136","author":"Bartel","year":"2009","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.cld.2025.08.004_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20112712","article-title":"Pathogenesis, early diagnosis, and therapeutic management of alcoholic liver disease","volume":"20","author":"Kong","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.cld.2025.08.004_bib18","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1002\/hep.25873","article-title":"Circulating microRNAs in exosomes indicate hepatocyte injury and inflammation in alcoholic, drug-induced, and inflammatory liver diseases","volume":"56","author":"Bala","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2025.08.004_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114582","article-title":"A novel epigenetic mechanism unravels hsa-miR-148a-3p-mediated CYP2B6 downregulation in alcoholic hepatitis disease","volume":"188","author":"Luo","year":"2021","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"10.1016\/j.cld.2025.08.004_bib20","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1124\/mol.120.119693","article-title":"MicroRNA hsa-miR-1301-3p regulates human","volume":"98","author":"Wang","year":"2020","journal-title":"Mol Pharmacol"},{"issue":"3","key":"10.1016\/j.cld.2025.08.004_bib21","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jcmgh.2015.04.003","article-title":"The gut microbiota and liver disease","volume":"1","author":"Llorente","year":"2015","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.cld.2025.08.004_bib22","doi-asserted-by":"crossref","first-page":"294","DOI":"10.3350\/cmh.2020.0057","article-title":"Fecal microbiota transplantation in alcohol related liver diseases","volume":"26","author":"Shasthry","year":"2020","journal-title":"Clin Mol Hepatol"},{"issue":"7783","key":"10.1016\/j.cld.2025.08.004_bib23","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/s41586-019-1742-x","article-title":"Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease","volume":"575","author":"Duan","year":"2019","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.cld.2025.08.004_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035008","article-title":"Effects of ethanol and acetaldehyde on tight junction integrity: in vitro study in a three dimensional intestinal epithelial cell culture model","volume":"7","author":"Elamin","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.cld.2025.08.004_bib25","doi-asserted-by":"crossref","first-page":"4630","DOI":"10.1038\/s41467-022-31973-2","article-title":"Acetate reprograms gut microbiota during alcohol consumption","volume":"13","author":"Martino","year":"2022","journal-title":"Nat Commun"},{"issue":"12","key":"10.1016\/j.cld.2025.08.004_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10123285","article-title":"Synbiotic intervention ameliorates oxidative stress and gut permeability in an in vitro and in vivo model of ethanol-induced intestinal dysbiosis","volume":"10","author":"Patel","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.cld.2025.08.004_bib27","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jnutbio.2018.10.016","article-title":"EGF receptor plays a role in the mechanism of glutamine-mediated prevention of alcohol-induced gut barrier dysfunction and liver injury","volume":"64","author":"Meena","year":"2019","journal-title":"J Nutr Biochem"},{"issue":"11","key":"10.1016\/j.cld.2025.08.004_bib28","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1111\/acer.13498","article-title":"Continued alcohol misuse in human cirrhosis is associated with an impaired gut-liver axis","volume":"41","author":"Bajaj","year":"2017","journal-title":"Alcohol Clin Exp Res"},{"issue":"2","key":"10.1016\/j.cld.2025.08.004_bib29","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/hep.30832","article-title":"Intestinal fungal dysbiosis and systemic immune response to fungi in patients with alcoholic hepatitis","volume":"71","author":"Lang","year":"2020","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.cld.2025.08.004_bib30","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.apsb.2014.12.011","article-title":"Role of farnesoid X receptor and bile acids in alcoholic liver disease","volume":"5","author":"Manley","year":"2015","journal-title":"Acta Pharm Sin B"},{"issue":"3","key":"10.1016\/j.cld.2025.08.004_bib31","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.gastha.2023.09.013","article-title":"Farnesoid X receptor agonists: a promising therapeutic strategy for gastrointestinal diseases","volume":"3","author":"Almeqdadi","year":"2024","journal-title":"Gastro Hep Adv"},{"issue":"2","key":"10.1016\/j.cld.2025.08.004_bib32","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1002\/med.21752","article-title":"Metabolites of microbiota response to tryptophan and intestinal mucosal immunity: a therapeutic target to control intestinal inflammation","volume":"41","author":"Zhang","year":"2021","journal-title":"Med Res Rev"},{"key":"10.1016\/j.cld.2025.08.004_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1258062","article-title":"Gut microbiota in alcohol-related liver disease: pathophysiology and gut-brain cross talk","volume":"14","author":"Zhu","year":"2023","journal-title":"Front Pharmacol"},{"issue":"1","key":"10.1016\/j.cld.2025.08.004_bib34","doi-asserted-by":"crossref","DOI":"10.1111\/adb.12702","article-title":"Brain GABA levels are reduced in alcoholic liver disease: a proton magnetic resonance spectroscopy study","volume":"25","author":"Morley","year":"2020","journal-title":"Addict Biol"},{"issue":"Pt B","key":"10.1016\/j.cld.2025.08.004_bib35","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.brainres.2018.03.015","article-title":"Neurotransmitter modulation by the gut microbiota","volume":"1693","author":"Strandwitz","year":"2018","journal-title":"Brain Res"},{"issue":"6","key":"10.1016\/j.cld.2025.08.004_bib36","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1002\/hep.28814","article-title":"Extracellular vesicles in liver pathobiology: small particles with big impact","volume":"64","author":"Hirsova","year":"2016","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.cld.2025.08.004_bib37","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1080\/21623945.2015.1017170","article-title":"Effect of alcohol on adipose tissue: a review on ethanol mediated adipose tissue injury","volume":"4","author":"Kema","year":"2015","journal-title":"Adipocyte"},{"issue":"12","key":"10.1016\/j.cld.2025.08.004_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0081949","article-title":"Pro-inflammatory activated Kupffer cells by lipids induce hepatic NKT cells deficiency through activation-induced cell death","volume":"8","author":"Tang","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.cld.2025.08.004_bib39","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1111\/liv.12575","article-title":"Alcohol withdrawal alleviates adipose tissue inflammation in patients with alcoholic liver disease","volume":"35","author":"Voican","year":"2015","journal-title":"Liver Int"},{"issue":"5","key":"10.1016\/j.cld.2025.08.004_bib40","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1097\/HEP.0000000000000670","article-title":"Metabolic dysfunction-associated steatotic liver disease: update and impact of new nomenclature on the American Association for the Study of Liver Diseases practice guidance on nonalcoholic fatty liver disease","volume":"79","author":"Kanwal","year":"2024","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.cld.2025.08.004_bib41","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.1038\/s41467-019-11004-3","article-title":"Defective HNF4alpha-dependent gene expression as a driver of hepatocellular failure in alcoholic hepatitis","volume":"10","author":"Argemi","year":"2019","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.cld.2025.08.004_bib42","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1055\/s-0040-1719177","article-title":"Insights into the role of granulocyte colony-stimulating factor in severe alcoholic hepatitis","volume":"41","author":"Kedarisetty","year":"2021","journal-title":"Semin Liver Dis"},{"issue":"2","key":"10.1016\/j.cld.2025.08.004_bib43","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/hep.31209","article-title":"Decreased hepatocyte autophagy leads to synergistic IL-1\u03b2 and TNF mouse liver injury and inflammation","volume":"72","author":"Shen","year":"2020","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.cld.2025.08.004_bib44","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/imr.12909","article-title":"The regulation of the ZBP1-NLRP3 inflammasome and its implications in pyroptosis, apoptosis, and necroptosis (PANoptosis)","volume":"297","author":"Zheng","year":"2020","journal-title":"Immunol Rev"},{"key":"10.1016\/j.cld.2025.08.004_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2025.116765","article-title":"Targeting GSDMD JX06 inhibits PANoptosis and multiple organ injury","volume":"233","author":"Chen","year":"2025","journal-title":"Biochem Pharmacol"},{"issue":"10","key":"10.1016\/j.cld.2025.08.004_bib46","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1111\/liv.15701","article-title":"Management of alcoholic hepatitis: a clinical perspective","volume":"43","author":"Kasper","year":"2023","journal-title":"Liver Int"},{"issue":"21","key":"10.1016\/j.cld.2025.08.004_bib47","doi-asserted-by":"crossref","first-page":"4060","DOI":"10.1111\/bph.14157","article-title":"The current state of GPCR-based drug discovery to treat metabolic disease","volume":"175","author":"Sloop","year":"2018","journal-title":"Br J Pharmacol"},{"issue":"6","key":"10.1016\/j.cld.2025.08.004_bib48","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1038\/s41591-022-01850-y","article-title":"Noninvasive proteomic biomarkers for alcohol-related liver disease","volume":"28","author":"Niu","year":"2022","journal-title":"Nat Med"},{"issue":"7","key":"10.1016\/j.cld.2025.08.004_bib49","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1136\/gutjnl-2012-303347","article-title":"Estrogen-related receptor \u03b3 controls hepatic CB1 receptor-mediated CYP2E1 expression and oxidative liver injury by alcohol","volume":"62","author":"Kim","year":"2013","journal-title":"Gut"},{"key":"10.1016\/j.cld.2025.08.004_bib50","doi-asserted-by":"crossref","DOI":"10.1038\/srep28806","article-title":"The cannabinoid receptor 2 protects against alcoholic liver disease via a macrophage autophagy-dependent pathway","volume":"6","author":"Dena\u00ebs","year":"2016","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.cld.2025.08.004_bib51","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1002\/hep.21607","article-title":"The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids","volume":"45","author":"Louvet","year":"2007","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.cld.2025.08.004_bib52","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1002\/hep.24524","article-title":"Cannabinoid CB2 receptors protect against alcoholic liver disease by regulating Kupffer cell polarization in mice","volume":"54","author":"Louvet","year":"2011","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.cld.2025.08.004_bib53","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.cmet.2019.08.001","article-title":"Glutamate signaling in hepatic stellate cells drives alcoholic steatosis","volume":"30","author":"Choi","year":"2019","journal-title":"Cell Metab"},{"issue":"5","key":"10.1016\/j.cld.2025.08.004_bib54","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1053\/j.gastro.2009.01.056","article-title":"Hepatic expression of CXC chemokines predicts portal hypertension and survival in patients with alcoholic hepatitis","volume":"136","author":"Dominguez","year":"2009","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.cld.2025.08.004_bib55","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1136\/gutjnl-2015-310344","article-title":"Reversal of murine alcoholic steatohepatitis by pepducin-based functional blockade of interleukin-8 receptors","volume":"66","author":"Wieser","year":"2017","journal-title":"Gut"},{"issue":"11","key":"10.1016\/j.cld.2025.08.004_bib56","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1136\/gutjnl-2013-306098","article-title":"CCL20 mediates lipopolysaccharide induced liver injury and is a potential driver of inflammation and fibrosis in alcoholic hepatitis","volume":"63","author":"Aff\u00f2","year":"2014","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.cld.2025.08.004_bib57","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1002\/hep.30249","article-title":"Pharmacological inhibition of CCR2\/5 signaling prevents and reverses alcohol-induced liver damage, steatosis, and inflammation in mice","volume":"69","author":"Ambade","year":"2019","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.cld.2025.08.004_bib58","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.jceh.2022.01.001","article-title":"Long-term outcomes of stool transplant in alcohol-associated hepatitis-analysis of clinical outcomes, relapse, gut microbiota and comparisons with standard care","volume":"12","author":"Philips","year":"2022","journal-title":"J Clin Exp Hepatol"},{"issue":"11","key":"10.1016\/j.cld.2025.08.004_bib59","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1097\/MEG.0000000000000458","article-title":"Effects of probiotics (cultured Lactobacillus subtilis\/Streptococcus faecium) in the treatment of alcoholic hepatitis: randomized-controlled multicenter study","volume":"27","author":"Han","year":"2015","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.cld.2025.08.004_bib60","article-title":"Granulocyte colony-stimulating factor for alcoholic hepatitis: a systematic review and meta-analysis of randomised controlled trials","volume":"2","author":"Marot","year":"2020","journal-title":"JHEP Rep"},{"issue":"2","key":"10.1016\/j.cld.2025.08.004_bib61","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/hep.31046","article-title":"An open-label, dose-escalation study to assess the safety and efficacy of IL-22 Agonist F-652 in patients with alcohol-associated hepatitis","volume":"72","author":"Arab","year":"2020","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.cld.2025.08.004_bib62","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1002\/hep.32478","article-title":"IL-1 receptor antagonist plus pentoxifylline and zinc for severe alcohol-associated hepatitis","volume":"76","author":"Szabo","year":"2022","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.cld.2025.08.004_bib63","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.jhep.2024.01.031","article-title":"Randomized trial of anakinra plus zinc vs. prednisone for severe alcohol-associated hepatitis","volume":"80","author":"Gawrieh","year":"2024","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.cld.2025.08.004_bib64","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.cgh.2024.07.025","article-title":"IL-1 signal inhibition in alcohol-related hepatitis: a randomized, double-blind, placebo-controlled trial of canakinumab","volume":"23","author":"Vergis","year":"2025","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.cld.2025.08.004_bib65","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.jceh.2017.11.006","article-title":"A placebo-controlled, multicenter, double-blind, phase 2 randomized trial of the pan-caspase inhibitor emricasan in patients with acutely decompensated cirrhosis","volume":"8","author":"Mehta","year":"2018","journal-title":"J Clin Exp Hepatol"},{"issue":"11","key":"10.1016\/j.cld.2025.08.004_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.labinv.2024.102134","article-title":"Involvement of BRD4 in alcoholic liver injury: autophagy modulation via regulation of the SIRT1\/Beclin1 Axis","volume":"104","author":"Liu","year":"2024","journal-title":"Lab Invest"}],"container-title":["Clinics in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326125000777?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326125000777?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T22:02:02Z","timestamp":1763762522000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089326125000777"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":66,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S1089326125000777"],"URL":"https:\/\/doi.org\/10.1016\/j.cld.2025.08.004","relation":{},"ISSN":["1089-3261"],"issn-type":[{"value":"1089-3261","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alcohol-Related Liver Disease","name":"articletitle","label":"Article Title"},{"value":"Clinics in Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cld.2025.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}